Pfizer starts Testing Covid Prevention Pill

Society » HEALTH | September 28, 2021, Tuesday // 17:48
Bulgaria: Pfizer starts Testing Covid Prevention Pill bing.com images

Pfizer announced today it has started a mid-to-late-stage study testing its oral antiviral drug for the prevention of Covid-19 infection among those who have been exposed to the virus, news wires reported. The company and its rivals, such as US-based Merck and Swiss Roche, have been racing to develop the first antiviral pill for Covid-19.

Pfizer said it would study the drug, PF-07321332, in up to 2,660 healthy adult participants aged 18 and older who live in the same household as an individual with a confirmed symptomatic Covid-19 infection. The trial would test the pill with a low dose of ritonavir, an older medication widely used in combination treatments for HIV infection.

Merck and its partner Ridgeback Biotherapeutics said earlier this month they had begun enrolling patients in a late-stage trial of their experimental drug molnupiravir for prevention of Covid-19 infection/Europost

We need your support so Novinite.com can keep delivering news and information about Bulgaria! Thank you!

Health » Be a reporter: Write and send your article
Tags: Pfizer parm, antiviral pills, covid prevention
Advertisement
Advertisement
Expats.bg All Are Welcome! Join Now!
Bulgaria news Novinite.com (Sofia News Agency - www.sofianewsagency.com) is unique with being a real time news provider in English that informs its readers about the latest Bulgarian news. The editorial staff also publishes a daily online newspaper "Sofia Morning News." Novinite.com (Sofia News Agency - www.sofianewsagency.com) and Sofia Morning News publish the latest economic, political and cultural news that take place in Bulgaria. Foreign media analysis on Bulgaria and World News in Brief are also part of the web site and the online newspaper. News Bulgaria